Kbc Group Nv Eli Lilly & CO Transaction History

Kbc Group Nv

$33.1 Billion
Q3 2024

A detailed history of Kbc Group Nv transactions in Eli Lilly & CO stock. As of the latest transaction made, Kbc Group Nv holds 565,835 shares of LLY stock, worth $423 Million. This represents 1.51% of its overall portfolio holdings.

Number of Shares

565,835

Previous 622,592 9.12%

Holding current value

$423 Million

Previous $564 Million 11.07%

% of portfolio

1.51%

Previous 1.7%

44 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$772.14 - $960.02 $43.8 Million - $54.5 Million	-56,757 Reduced 9.12%	565,835 $501 Million
Q2 2024 Jul 17, 2024	BUY	$724.87 - $909.04 $104 Million - $130 Million	143,341 Added 29.91%	622,592 $564 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $56.3 Million - $75.4 Million	-95,144 Reduced 16.56%	479,251 $373 Million
Q4 2023 Feb 13, 2024	SELL	$525.19 - $619.13 $35.7 Million - $42.1 Million	-67,939 Reduced 10.58%	574,395 $335 Million
Q3 2023 Feb 15, 2024	SELL	$434.7 - $599.3 $41.8 Million - $57.6 Million	-96,151 Reduced 14.89%	549,788 $295 Million
Q2 2023 Feb 15, 2024	SELL	$350.74 - $468.98 $53.2 Million - $71.1 Million	-151,660 Reduced 19.01%	645,939 $303 Million
Q2 2023 Jul 28, 2023	BUY	$350.74 - $468.98 $47.5 Million - $63.5 Million	135,414 Added 26.71%	642,334 $301 Million
Q1 2023 Feb 14, 2024	SELL	$310.63 - $364.82 $40.8 Million - $48 Million	-131,501 Reduced 18.85%	566,166 $194 Million
Q1 2023 May 04, 2023	SELL	$310.63 - $364.82 $89.9 Million - $106 Million	-289,463 Reduced 36.35%	506,920 $174 Million
Q4 2022 Feb 14, 2024	BUY	$321.55 - $374.67 $30 Million - $34.9 Million	93,235 Added 15.43%	697,667 $255 Million
Q3 2022 Feb 15, 2024	BUY	$296.48 - $337.87 $66.2 Million - $75.4 Million	223,204 Added 38.86%	797,599 $258 Million
Q3 2022 Nov 08, 2022	BUY	$296.48 - $337.87 $57.3 Million - $65.4 Million	193,428 Added 32.08%	796,383 $258 Million
Q2 2022 Feb 14, 2024	SELL	$278.73 - $327.27 $17.5 Million - $20.6 Million	-62,893 Reduced 9.42%	604,432 $196 Million
Q2 2022 Jul 26, 2022	SELL	$278.73 - $327.27 $17.9 Million - $21.1 Million	-64,370 Reduced 9.65%	602,955 $195 Million
Q1 2022 Feb 14, 2024	SELL	$234.69 - $291.66 $15.6 Million - $19.4 Million	-66,424 Reduced 9.05%	667,325 $191 Million
Q1 2022 May 06, 2022	SELL	$234.69 - $291.66 $15.6 Million - $19.4 Million	-66,424 Reduced 9.05%	667,325 $191 Million
Q4 2021 Feb 14, 2024	BUY	$224.85 - $279.04 $35.8 Million - $44.5 Million	159,354 Added 27.74%	733,749 $203 Million
Q4 2021 Feb 03, 2022	BUY	$224.85 - $279.04 $39.3 Million - $48.8 Million	174,964 Added 31.31%	733,749 $203 Million
Q3 2021 Nov 10, 2021	BUY	$221.6 - $272.71 $12 Million - $14.7 Million	54,046 Added 10.71%	558,785 $129 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $7.18 Million - $9.28 Million	-39,751 Reduced 7.3%	504,739 $116 Million
Q1 2021 Apr 26, 2021	SELL	$164.32 - $212.72 $16.4 Million - $21.3 Million	-100,024 Reduced 15.52%	544,490 $102 Million
Q4 2020 Feb 10, 2021	BUY	$130.46 - $172.63 $41.5 Million - $54.9 Million	317,837 Added 97.29%	644,514 $109 Million
Q3 2020 Oct 28, 2020	BUY	$146.22 - $169.13 $12 Million - $13.9 Million	82,011 Added 33.52%	326,677 $48.4 Million
Q2 2020 Aug 10, 2020	SELL	$136.42 - $164.18 $21.6 Million - $26 Million	-158,519 Reduced 39.32%	244,666 $40.2 Million
Q1 2020 May 04, 2020	BUY	$119.05 - $147.35 $7.29 Million - $9.02 Million	61,221 Added 17.9%	403,185 $55.9 Million
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $9.3 Million - $11.5 Million	-86,989 Reduced 20.28%	341,964 $44.9 Million
Q3 2019 Nov 07, 2019	BUY	$106.79 - $116.16 $45.7 Million - $49.7 Million	427,531 Added 30065.47%	428,953 $48 Million
Q2 2019 Dec 03, 2019	SELL	$110.79 - $129.32 $62.4 Million - $72.8 Million	-562,846 Reduced 99.75%	1,422 $158,000
Q2 2019 Jul 30, 2019	BUY	$110.79 - $129.32 $62.4 Million - $72.8 Million	562,846 Added 39581.29%	564,268 $0
Q1 2019 Dec 03, 2019	SELL	$111.31 - $131.02 $57 Million - $67 Million	-511,715 Reduced 99.72%	1,422 $185,000
Q1 2019 May 10, 2019	BUY	$111.31 - $131.02 $57 Million - $67 Million	511,715 Added 35985.58%	513,137 $0
Q4 2018 Dec 03, 2019	SELL	$105.9 - $118.64 $32.8 Million - $36.8 Million	-310,128 Reduced 99.54%	1,422 $165,000
Q4 2018 Jan 31, 2019	BUY	$105.9 - $118.64 $32.8 Million - $36.7 Million	309,428 Added 14581.9%	311,550 $36.1 Million
Q3 2018 Dec 03, 2019	SELL	$85.86 - $107.31 $26.1 Million - $32.6 Million	-303,461 Reduced 99.31%	2,122 $228,000
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $26.1 Million - $32.6 Million	303,461 Added 14300.71%	305,583 $0
Q2 2018 Dec 03, 2019	SELL	$75.7 - $86.88 $36 Million - $41.3 Million	-475,020 Reduced 99.56%	2,122 $181,000
Q2 2018 Aug 03, 2018	BUY	$75.7 - $86.88 $36 Million - $41.3 Million	475,020 Added 22385.49%	477,142 $0
Q1 2018 Dec 03, 2019	SELL	$74.21 - $87.6 $39.5 Million - $46.7 Million	-532,913 Reduced 99.6%	2,122 $164,000
Q1 2018 May 09, 2018	BUY	$74.21 - $87.6 $39.5 Million - $46.7 Million	532,913 Added 25113.71%	535,035 $0
Q4 2017 Dec 03, 2019	SELL	$81.94 - $87.89 $43.9 Million - $47.1 Million	-535,796 Reduced 99.61%	2,122 $179,000
Q4 2017 Feb 07, 2018	BUY	$81.94 - $87.89 $43.9 Million - $47.1 Million	535,796 Added 25249.58%	537,918 $0
Q3 2017 Dec 03, 2019	SELL	$77.07 - $85.54 $60.1 Million - $66.7 Million	-780,315 Reduced 99.73%	2,122 $182,000
Q3 2017 Nov 13, 2017	BUY	$77.07 - $85.54 $60.1 Million - $66.7 Million	780,315 Added 36772.62%	782,437 $0
Q2 2017 Dec 03, 2019	BUY	N/A	2,122	2,122 $175,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Account